Viewing Study NCT00063934


Ignite Creation Date: 2025-12-25 @ 2:22 AM
Ignite Modification Date: 2026-01-06 @ 3:10 PM
Study NCT ID: NCT00063934
Status: TERMINATED
Last Update Posted: 2019-03-05
First Post: 2003-07-08
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer
Sponsor: National Cancer Institute (NCI)
Organization: